HSRx 431
Alternative Names: HSRx 431; HSRx431Latest Information Update: 28 Oct 2020
Price :
$50 *
At a glance
- Originator HerbalScience Group
- Developer HSRx Biopharmaceutical
- Class Antivirals
- Mechanism of Action Virus internalisation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Chikungunya virus infections; Dengue; Zika virus infection
Most Recent Events
- 28 Oct 2020 No recent reports of development identified for preclinical development in Dengue in USA (PO)
- 28 Jan 2020 No recent reports of development identified for phase-I development in Chikungunya-virus-infections in Unknown (PO)
- 28 Jan 2020 No recent reports of development identified for phase-I development in Zika-virus-infection in Unknown (PO)